These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Differential mapping of Fc gamma-binding and monoclonal antibody-reactive epitopes on gE, the Fc gamma-binding glycoprotein of herpes simplex virus type 1. Williams RC, Kievit E, Tsuchiya N, Malone C, Hutt-Fletcher L. J Immunol; 1992 Oct 01; 149(7):2415-27. PubMed ID: 1382102 [Abstract] [Full Text] [Related]
23. Computational prediction of the binding site of proteinase 3 to the plasma membrane. Hajjar E, Mihajlovic M, Witko-Sarsat V, Lazaridis T, Reuter N. Proteins; 2008 Jun 01; 71(4):1655-69. PubMed ID: 18076025 [Abstract] [Full Text] [Related]
24. Expression of recombinant proteinase 3, the autoantigen in Wegener's granulomatosis, in insect cells. Van der Geld YM, Smook ML, Huitema MG, Harmsen MC, Limburg PC, Kallenberg CG. J Immunol Methods; 2002 Jun 01; 264(1-2):195-205. PubMed ID: 12191522 [Abstract] [Full Text] [Related]
25. Constitutive membrane expression of proteinase 3 (PR3) and neutrophil activation by anti-PR3 antibodies. van Rossum AP, Rarok AA, Huitema MG, Fassina G, Limburg PC, Kallenberg CG. J Leukoc Biol; 2004 Dec 01; 76(6):1162-70. PubMed ID: 15331626 [Abstract] [Full Text] [Related]
26. Autoantibodies to neutrophil cytoplasmic antigens (ANCA) do not bind to polymorphonuclear neutrophils in blood. Abdel-Salam B, Iking-Konert C, Schneider M, Andrassy K, Hänsch GM. Kidney Int; 2004 Sep 01; 66(3):1009-17. PubMed ID: 15327394 [Abstract] [Full Text] [Related]
27. Characterization of monoclonal antibodies to proteinase-3 and application in the study of epitopes for classical anti-neutrophil cytoplasm antibodies. Sommarin Y, Rasmussen N, Wieslander J. Exp Nephrol; 1995 Sep 01; 3(4):249-56. PubMed ID: 8590038 [Abstract] [Full Text] [Related]
28. Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies. Choi HK, Liu S, Merkel PA, Colditz GA, Niles JL. J Rheumatol; 2001 Jul 01; 28(7):1584-90. PubMed ID: 11469466 [Abstract] [Full Text] [Related]
29. Variations in performance characteristics of commercial enzyme immunoassay kits for detection of antineutrophil cytoplasmic antibodies: what is the optimal cut off? Holle JU, Hellmich B, Backes M, Gross WL, Csernok E. Ann Rheum Dis; 2005 Dec 01; 64(12):1773-9. PubMed ID: 15843447 [Abstract] [Full Text] [Related]
32. Activation, apoptosis, and clearance of neutrophils in Wegener's granulomatosis. van Rossum AP, Limburg PC, Kallenberg CG. Ann N Y Acad Sci; 2005 Jun 01; 1051():1-11. PubMed ID: 16126939 [Abstract] [Full Text] [Related]
33. Detachment and cytolysis of human endothelial cells by proteinase 3. Ballieux BE, Hiemstra PS, Klar-Mohamad N, Hagen EC, van Es LA, van der Woude FJ, Daha MR. Eur J Immunol; 1994 Dec 01; 24(12):3211-5. PubMed ID: 7805749 [Abstract] [Full Text] [Related]
34. Epitope mapping of anti-proteinase 3 and anti-myeloperoxidase antibodies. Chang L, Binos S, Savige J. Clin Exp Immunol; 1995 Oct 01; 102(1):112-9. PubMed ID: 7554377 [Abstract] [Full Text] [Related]
35. What you should know about PR3-ANCA. Structural aspects of antibodies to proteinase 3 (PR3). Peen E, Williams RC. Arthritis Res; 2000 Oct 01; 2(4):255-9. PubMed ID: 11094437 [Abstract] [Full Text] [Related]
37. A substrate-based approach to convert SerpinB1 into a specific inhibitor of proteinase 3, the Wegener's granulomatosis autoantigen. Jégot G, Derache C, Castella S, Lahouassa H, Pitois E, Jourdan ML, Remold-O'Donnell E, Kellenberger C, Gauthier F, Korkmaz B. FASEB J; 2011 Sep 01; 25(9):3019-31. PubMed ID: 21670065 [Abstract] [Full Text] [Related]
38. Characterization of monoclonal antibodies to proteinase 3 (PR3) as candidate tools for epitope mapping of human anti-PR3 autoantibodies. Van Der Geld YM, Limburg PC, Kallenberg CG. Clin Exp Immunol; 1999 Dec 01; 118(3):487-96. PubMed ID: 10594572 [Abstract] [Full Text] [Related]
39. Selective killing of B-cell hybridomas targeting proteinase 3, Wegener's autoantigen. Reiners KS, Hansen HP, Krüssmann A, Schön G, Csernok E, Gross WL, Engert A, Von Strandmann EP. Immunology; 2004 Jun 01; 112(2):228-36. PubMed ID: 15147566 [Abstract] [Full Text] [Related]
40. Proteinase 3: substrate specificity and possible pathogenetic effect of Wegener's granulomatosis autoantibodies (c-ANCA) by dysregulation of the enzyme. Dolman KM, van de Wiel BA, Kam CM, Kerrigan JE, Hack CE, von dem Borne AE, Powers JC, Goldschmeding R. Adv Exp Med Biol; 1993 Jun 01; 336():55-60. PubMed ID: 8296674 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]